Latest Pro/Con Debate

Pro: High dose of therapeutic plasma exchange Mind the gap!

Carsten Hafer and Jan T. Kielstein

269 KB | 11.07.2017 13:16

Management of patients at risk of acute kidney injury

Jill Vanmassenhove, Jan Kielstein, Achim Jörres, Wim Van Biesen

677 KB | 11.06.2017 11:35

Boliden auf der Intensivstation - Wie viel Antibiotika verbraucht Ihre Nierenersatztherapie pro Tag?

J. T. Kielstein, A. K. Kruse, N. Anderson, H. Vaitiekunas, S. Scherneck

387 KB | 01.06.2017 12:36

Nephrologie trifft Toxikologie: Akute Nierenschädigungen durch Intoxikationen und mehr

S. Herget-Rosenthal. J. T. Kielstein

636 KB | 06.05.2017 10:28

Ultrasound findings in EHEC‑associated hemolytic‑uremicsyndrome and their clinical relevance

Ansgar Reising, Carsten Hafer, Marcus Hiss, Jan T. Kielstein, Jan Menne, Faikah Gueler, Jan Beneke, Silvia Linnenweber‑Held, Hermann Haller, Gunilla Einecke

903 KB | 06.05.2017 10:29

Membrane versus centrifuge-basedtherapeutic plasma exchange: arandomized prospective crossover study

Carsten Hafer, Paulina Golla, Marion Gericke, Gabriele Eden, Gernot Beutel, Julius J. Schmidt, Bernhard M. W. Schmidt, et al.

821 KB | 06.05.2017 10:30

Involvement of Angiopoietin-2 and Tie2Receptor Phosphorylation in STEC-HUS Mediated by Escherichia coli O104:H4

Alexander Lukasz, Jan Beneke, Kristina Thamm, Jan T. Kielstein, JanMenne, Jan-Henrik Mikesch, Bernhard M. W. Schmidt, Hermann Haller, Philipp Kümpers, Sascha David and Mario Schiffer

4 MB | 06.05.2017 10:31

Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study

Carsten Hafer, Paulina Golla, Marion Gericke, Gabriele Eden, Gernot Beutel, Julius J. Schmidt, Bernhard M. W. Schmidt, Stef De Reys, Jan T. Kielstein

632 KB | 06.05.2017 10:32

Role of the endogenous nitric oxide inhibitor ADMA and BDNF in depression and behavioural changes: clinical and preclinical data in chronic kidney disease

Heike Kielstein,Mayuren Suntharalingam, Ronny Perthel, Rong Song, Sabrina M. Schneider, Jens Martens-Lobenhoffer, Kristin Jäger, Stefanie M. Bode-Böger, Jan T. Kielstein

286 KB | 06.05.2017 10:33

Extracorporeal Treatment for Salicylate Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup

David N. Juurlink, MD; Sophie Gosselin, MD; Jan T. Kielstein, MD; Marc Ghannoum, MD; Valéry Lavergne, MD, MSc; Thomas D. Nolin, PharmD, PhD; Robert S. Hoffman, MD*; on behalf of the EXTRIP Workgroup†

2 MB | 06.05.2017 10:36

Nierenersatzverfahren und Plasmapherese

Julius J. Schmidt, Jan T. Kielstein

452 KB | 06.05.2017 10:36

Therapy of Treatment-Related Hypertension in Metastatic Renal-Cell Cancer Patients Receiving Sunitinib

Philipp Ivanyi, Gernot Beutel, Nicole Drewes, Jens Pirr, Jan T. Kielstein, Michael Morgan, Arnold Ganser, Viktor Grünwald

774 KB | 06.05.2017 10:24

Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin–Mediated Hemolytic Uremic Syndrome

Jan Beneke, Aleksej Sartison, Jan T. Kielstein, Hermann Haller, Martin Nitschke, Ulrich Kunzendorf, Sebastian Loos, Markus J. Kemper, Rolf A.K. Stahl, Jan Menne for the German 2011 STEC-HUS outbreak study group

709 KB | 06.05.2017 10:25

Health status, renal function, and quality of life after multiorgan failure and acute kidney injury requiring renal replacement therapy

Robert Faulhaber-Walter, Sebastian Scholz, Herrmann Haller, Jan T Kielstein, Carsten Hafer

361 KB | 06.05.2017 10:26

Neurological Sequelae in Adults After E coli O104:H4 Infection-Induced Hemolytic-Uremic Syndrome

Ramona Schuppner, MD, Justus Maehlmann, Meike Dirks, MD, Hans Worthmann, MD,Anita B. Tryc, MD, Kajetan Sandorski, Elisabeth Bahlmann, MD, Jan T. Kielstein, MD,Anja M. Giesemann, MD, Heinrich Lanfermann, MD, and Karin Weissenborn, MD

318 KB | 06.05.2017 10:27